OBJECTIVES: Military members are required to complete the Post-Deployment Health Assessment on return from deployment and the Post-Deployment Health Reassessment (PHDRA) 90 to 180 days later, and we assessed the PDHRA's sensitivity and specificity in identifying posttraumatic stress disorder (PTSD) and depression after a military deployment among US Air Force personnel. METHODS: We computed the PDHRA's sensitivity and specificity for depression and PTSD and developed a structural model to suggest possible improvements to it. RESULTS: For depression, sensitivity and specificity were 0.704 and 0.651, respectively; for PTSD, they were 0.774 and 0.650, respectively. Several variables produced significant direct effects on depression and trauma, suggesting that modifications could increase its sensitivity and specificity. CONCLUSIONS: The PDHRA was moderately effective in identifying airmen with depression and PTSD. It identified behavioral health concerns in many airmen who did not develop a diagnostic mental health condition. Its low level of specificity may result in reduced barriers to care and increased support services, key components of a public health approach to suicide prevention, for airmen experiencing subacute levels of distress after deployment, which may, in part, account for lower suicide rates among airmen after deployment.
OBJECTIVES: Military members are required to complete the Post-Deployment Health Assessment on return from deployment and the Post-Deployment Health Reassessment (PHDRA) 90 to 180 days later, and we assessed the PDHRA's sensitivity and specificity in identifying posttraumatic stress disorder (PTSD) and depression after a military deployment among US Air Force personnel. METHODS: We computed the PDHRA's sensitivity and specificity for depression and PTSD and developed a structural model to suggest possible improvements to it. RESULTS: For depression, sensitivity and specificity were 0.704 and 0.651, respectively; for PTSD, they were 0.774 and 0.650, respectively. Several variables produced significant direct effects on depression and trauma, suggesting that modifications could increase its sensitivity and specificity. CONCLUSIONS: The PDHRA was moderately effective in identifying airmen with depression and PTSD. It identified behavioral health concerns in many airmen who did not develop a diagnostic mental health condition. Its low level of specificity may result in reduced barriers to care and increased support services, key components of a public health approach to suicide prevention, for airmen experiencing subacute levels of distress after deployment, which may, in part, account for lower suicide rates among airmen after deployment.
Authors: David W Niebuhr; Rebekah L Krampf; Jonathan A Mayo; Caitlin D Blandford; Lynn I Levin; David N Cowan Journal: Mil Med Date: 2011-02 Impact factor: 1.437
Authors: Charles B Nemeroff; J Douglas Bremner; Edna B Foa; Helen S Mayberg; Carol S North; Murray B Stein Journal: J Psychiatr Res Date: 2005-10-18 Impact factor: 4.791
Authors: William D S Killgore; Dave I Cotting; Jeffrey L Thomas; Anthony L Cox; Dennis McGurk; Alexander H Vo; Carl A Castro; Charles W Hoge Journal: J Psychiatr Res Date: 2008-03-04 Impact factor: 4.791
Authors: Kenneth R Conner; Michael D McCarthy; Alina Bajorska; Eric D Caine; Xin M Tu; Kerry L Knox Journal: Suicide Life Threat Behav Date: 2012-10-24
Authors: Matthew K Nock; Charlene A Deming; Carol S Fullerton; Stephen E Gilman; Matthew Goldenberg; Ronald C Kessler; James E McCarroll; Katie A McLaughlin; Christopher Peterson; Michael Schoenbaum; Barbara Stanley; Robert J Ursano Journal: Psychiatry Date: 2013 Impact factor: 2.458